Healios K.K.
HLOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $560,000 | $121,000 | $90,000 | $41,000 |
| % Growth | 362.8% | 34.4% | 119.5% | – |
| Cost of Goods Sold | $128,000 | $13,000 | $0 | $0 |
| Gross Profit | $432,000 | $108,000 | $90,000 | $41,000 |
| % Margin | 77.1% | 89.3% | 100% | 100% |
| R&D Expenses | $1,960,000 | $2,304,000 | $3,808,000 | $3,700,000 |
| G&A Expenses | $1,374,000 | $1,184,000 | $1,449,000 | $1,722,000 |
| SG&A Expenses | $1,374,000 | $1,184,000 | $1,449,000 | $1,722,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$59,000 | -$1,000 | $12,000 | $3,000 |
| Operating Expenses | $3,275,000 | $3,487,000 | $5,269,000 | $5,425,000 |
| Operating Income | -$2,843,000 | -$3,379,000 | -$5,179,000 | -$5,384,000 |
| % Margin | -507.7% | -2,792.6% | -5,754.4% | -13,131.7% |
| Other Income/Exp. Net | -$1,218,000 | -$247,000 | -$151,000 | $923,000 |
| Pre-Tax Income | -$4,061,000 | -$3,626,000 | -$5,330,000 | -$4,462,000 |
| Tax Expense | $166,000 | $187,000 | -$160,000 | $450,000 |
| Net Income | -$4,235,000 | -$3,823,000 | -$5,170,000 | -$4,912,000 |
| % Margin | -756.3% | -3,159.5% | -5,744.4% | -11,980.5% |
| EPS | -47.87 | -56.22 | -90.69 | -93.4 |
| % Growth | 14.9% | 38% | 2.9% | – |
| EPS Diluted | -47.87 | -56.22 | -90.69 | -93.4 |
| Weighted Avg Shares Out | 88,473 | 68,001 | 57,010 | 52,592 |
| Weighted Avg Shares Out Dil | 88,473 | 68,004 | 57,010 | 52,592 |
| Supplemental Information | – | – | – | – |
| Interest Income | $373,000 | $456,000 | $346,000 | $1,728,000 |
| Interest Expense | $1,589,000 | $704,000 | $500,000 | $802,000 |
| Depreciation & Amortization | $297,000 | $224,000 | $386,000 | $262,000 |
| EBITDA | -$2,175,000 | -$2,698,000 | -$4,771,000 | -$5,117,000 |
| % Margin | -388.4% | -2,229.8% | -5,301.1% | -12,480.5% |